Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Why Teva Pharmaceutical Industries Shot Higher Today
04:34pm, Tuesday, 28'th Sep 2021
The company reached a settlement in a legal dispute with the state of Louisiana.
Is It Time to Buy Warren Buffett's Lowest-Priced Stock?
08:40am, Wednesday, 22'nd Sep 2021
Is Berkshire Hathaway's lowest per-share stock a buy?
Is Now the Time to Ditch Pharma Stocks?
06:45am, Tuesday, 21'st Sep 2021
With drug pricing reform on the horizon, investors may want to analyze their allocation.
5 Berkshire Hathaway Stocks in Downtrends
03:00pm, Friday, 17'th Sep 2021
Not everything goes up all the time on Wall Street, and no one expects that. Buyers of value stocks typically are prepared to wait for the longer term to play out.
Teva: Cautiously Bullish On 5-Year Prospects
09:15am, Friday, 17'th Sep 2021
Teva has faced scandal after scandal which soured investors and the general public alike. Even though I think the $40.5 billion Actavis acquisition was a good move, it leveraged Teva to uncomfortable
3 Discounted Buffett Stocks to Buy Hand Over Fist in September
05:51am, Wednesday, 08'th Sep 2021
Riding the Oracle of Omaha's coattails has historically been a smart move for investors.
Teva's (TEVA) NDA for Schizophrenia Drug Gets FDA Acceptance
01:47pm, Wednesday, 01'st Sep 2021
The FDA accepts Teva Pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone, a potential treatment for schizophrenia.
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
07:27am, Wednesday, 01'st Sep 2021
The FDA has accepted Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and MedinCell's marketing application seeking approval for TV-46000/mdc-IRM in schizophrenia. TV-46000/mdc-IRM is a risperid
PARSIPPANY, N.J., TEL AVIV & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced toda
3 Generic Drug Stocks to Watch Amid Pandemic & Pricing Pressure
12:10pm, Tuesday, 17'th Aug 2021
The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in
Digging into the moves in big cap pharma
07:13pm, Monday, 16'th Aug 2021
Retailers are on deck to report earnings this week, but some macro headwinds could create uncertainty for the group.
Why Teva Pharmaceuticals Has Two A-Products In The Bag
04:38pm, Tuesday, 10'th Aug 2021
Why Teva Pharmaceuticals Has Two A-Products In The Bag
Teva: Maximum Optimism
03:35pm, Wednesday, 04'th Aug 2021
Teva is one of the largest pharmaceutical companies in the world and the second largest generic medicine company (after Viatris) in terms of revenue.
TEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock Up
12:10pm, Thursday, 29'th Jul 2021
TEVA beats on second-quarter earnings but misses on sales. The company lowers 2021 sales view.
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q2 2021 Results - Earnings Call Transcript
01:43pm, Wednesday, 28'th Jul 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q2 2021 Results - Earnings Call Transcript
